Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system
复制标题
DOI：
10.1016/s0010-7824(99)00075-x
复制
发表时间：
1999-09-01
期刊：
影响因子：
2.9
通讯作者：
Singh, K
中科院分区：
文献类型：
--
作者：
Fong, YF;Singh, K
子宫腺肌病是月经过多的重要原因。除了子宫切除术，子宫腺肌病的治疗选择也很有限。本文介绍一例子宫腺肌病的成功治疗，该妇女表现为月经过多、痛经和子宫增大，采用甲芬那酸保守治疗不能令人满意，患者植入了左旋诺格Estrel释放系统(LNG-IUS)。子宫大小在植入后12个月内明显缩小，并伴有月经过多和痛经的缓解。因此，LNG-IUS是一个可行的选择，代表着子宫腺肌病治疗的真正进步。(C)1999 Elsevier Science Inc.保留所有权利。
Adenomyosis is an important cause of menorrhagia. Besides hysterectomy, the treatment options for adenomyosis have been limited. Presented here is the successful treatment of adenomyosis in a woman presenting with menorrhagia, dysmenorrhea, and an enlarging uterus, for whom conservative therapy initiated with mefenamic acid was unsatisfactory, The patient had insertion of the levonorg estrel-releasing intrauterine system (LNG-IUS). A marked decrease in uterine size occurred within 12 months of insertion accompanied by resolution of the menorrhagia and dysmenorrhea. Thus, the LNG-IUS is a viable option and represents a real advance in the treatment of adenomyosis. (C) 1999 Elsevier Science Inc. All rights reserved.